Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies

NCT00598624 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT00598624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00598624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2005
Completion date
December 31, 2010
Enrollment
175 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, chronic myeloid leukemia, diffuse large cell lymphoma, hodgkin lymphoma, leukemia, multiple myeloma, myelodysplastic syndrome